Georgie Buswell summarises a cross-sectional study, which used open questions to try and understand people’s lived experiences of taking antipsychotic drugs.
[read the full story...]Psychological interventions effective for improving mental health and sleep following complex trauma
In her debut blog, Delia Ciobotaru explores a network meta-analysis which finds that psychological treatments are effective in reducing PTSD symptoms experienced by people with complex trauma.
[read the full story...]Experience of psychotropic medication and decision-making
Jennifer Rose Oulton reviews a qualitative study that explores the experiences of psychotropic medication use and decision-making for adults with learning disabilities and their carers.
[read the full story...]Antipsychotics versus CBT in first episode psychosis: some answers, more questions
Joe Pierre summarises two recently published and widely reported RCTs, which suggest that antipsychotic medication might not offer an advantage over psychotherapy in broadly-defined first episode psychosis.
[read the full story...]Sex and schizophrenia: what determines sexual interest and confidence?
In her debut blog, Beccy White summarises a secondary analysis which explored predictors of sexual interest amongst older adults with schizophrenia.
[read the full story...]Antipsychotics for schizophrenia: do they provide a longer, healthier life?
Paul Heron from the Closing the Gap Network writes his debut blog about a 20‐year cohort study of physical morbidity and mortality in relationship to antipsychotic treatment in a huge group of people with schizophrenia in Finland.
[read the full story...]Risperidone and aripiprazole: genotype, metabolism and dosage
Dolly Sud writes her debut elf blog on a recent retrospective analysis, which compares dose changes of risperidone and aripiprazole with patients’ individual genotype.
[read the full story...]Antipsychotics and metabolic function in people with schizophrenia
Peter Haddad and Sami Ouanes review a network meta-analysis of the impact of antipsychotic drugs on metabolic function in people with schizophrenia.
[read the full story...]The Trial: pharmacotherapy versus psychotherapy for schizophrenia – how do trials compare?
Keith Laws looks at a systematic review of patient and study characteristics, which asks: are randomised controlled trials on pharmacotherapy and psychotherapy for positive symptoms of schizophrenia comparable?
[read the full story...]Cognitive functioning in psychosis: is neuropsychological decline continuous, generalised, and specific to schizophrenia?
Emmeline Lagunes Cordoba and Derek Tracy explore a case control study that looks at cognitive change in people with schizophrenia and other psychoses in the decade following the first episode.
[read the full story...]